Annual Current Liabilities
$15.28 B
-$3.34 B-17.95%
March 31, 2024
Summary
- As of February 7, 2025, TAK annual total current liabilities is $15.28 billion, with the most recent change of -$3.34 billion (-17.95%) on March 31, 2024.
- During the last 3 years, TAK annual current liabilities has fallen by -$791.17 million (-4.92%).
- TAK annual current liabilities is now -33.63% below its all-time high of $23.03 billion, reached on March 31, 2019.
Performance
TAK Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$13.36 B
-$3.36 B-20.07%
December 1, 2024
Summary
- As of February 7, 2025, TAK quarterly total current liabilities is $13.36 billion, with the most recent change of -$3.36 billion (-20.07%) on December 1, 2024.
- Over the past year, TAK quarterly current liabilities has dropped by -$3.36 billion (-20.07%).
- TAK quarterly current liabilities is now -41.98% below its all-time high of $23.03 billion, reached on March 31, 2019.
Performance
TAK Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TAK Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.9% | -20.1% |
| 3 y3 years | -4.9% | -28.3% |
| 5 y5 years | -33.6% | -16.9% |
TAK Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.9% | at low | -28.3% | at low |
| 5 y | 5-year | -33.6% | at low | -33.6% | at low |
| alltime | all time | -33.6% | +457.6% | -42.0% | +221.3% |
Takeda Pharmaceutical Company Limited Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $13.36 B(-20.1%) |
| Sep 2024 | - | $16.72 B(+9.1%) |
| Jun 2024 | - | $15.32 B(+0.2%) |
| Mar 2024 | $15.28 B(-18.0%) | $15.28 B(-5.6%) |
| Dec 2023 | - | $16.18 B(+2.1%) |
| Sep 2023 | - | $15.85 B(-8.3%) |
| Jun 2023 | - | $17.28 B(-7.2%) |
| Mar 2023 | $18.63 B(+6.0%) | $18.63 B(+9.2%) |
| Dec 2022 | - | $17.06 B(+3.0%) |
| Sep 2022 | - | $16.56 B(+4.4%) |
| Jun 2022 | - | $15.86 B(-9.8%) |
| Mar 2022 | $17.58 B(+9.4%) | $17.58 B(+11.8%) |
| Dec 2021 | - | $15.72 B(-8.3%) |
| Sep 2021 | - | $17.14 B(+11.0%) |
| Jun 2021 | - | $15.44 B(-3.9%) |
| Mar 2021 | $16.07 B(-20.2%) | $16.07 B(-8.2%) |
| Dec 2020 | - | $17.50 B(+8.2%) |
| Sep 2020 | - | $16.18 B(-14.3%) |
| Jun 2020 | - | $18.88 B(-6.2%) |
| Mar 2020 | $20.13 B(-12.6%) | $20.13 B(+3.1%) |
| Dec 2019 | - | $19.54 B(+29.0%) |
| Sep 2019 | - | $15.14 B(-18.6%) |
| Jun 2019 | - | $18.60 B(-19.2%) |
| Mar 2019 | $23.03 B(+231.8%) | $23.03 B(+191.5%) |
| Dec 2018 | - | $7.90 B(+6.4%) |
| Sep 2018 | - | $7.43 B(+11.9%) |
| Jun 2018 | - | $6.64 B(-4.4%) |
| Mar 2018 | $6.94 B(-43.2%) | $6.94 B(-10.9%) |
| Dec 2017 | - | $7.79 B(+4.5%) |
| Sep 2017 | - | $7.46 B(-11.1%) |
| Jun 2017 | - | $8.39 B(-31.4%) |
| Mar 2017 | $12.22 B(+60.2%) | $12.22 B(+48.4%) |
| Dec 2016 | - | $8.24 B(+3.1%) |
| Sep 2016 | - | $7.99 B(-0.2%) |
| Jun 2016 | - | $8.00 B(+4.9%) |
| Mar 2016 | $7.63 B | $7.63 B(-9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | - | $8.39 B(+2.1%) |
| Sep 2015 | - | $8.22 B(-0.2%) |
| Jun 2015 | - | $8.24 B(-2.7%) |
| Mar 2015 | $8.47 B(+8.6%) | $8.47 B(+20.8%) |
| Dec 2014 | - | $7.01 B(-1.5%) |
| Sep 2014 | - | $7.12 B(-2.5%) |
| Jun 2014 | - | $7.30 B(-6.4%) |
| Mar 2014 | $7.80 B(+15.9%) | $7.80 B(+40.9%) |
| Dec 2013 | - | $5.54 B(-0.9%) |
| Sep 2013 | - | $5.59 B(+1.3%) |
| Jun 2013 | - | $5.52 B(-18.0%) |
| Mar 2013 | $6.73 B(-27.0%) | $6.73 B(+1.0%) |
| Dec 2012 | - | $6.66 B(+5.9%) |
| Sep 2012 | - | $6.29 B(-31.3%) |
| Jun 2012 | - | $9.15 B(-0.8%) |
| Mar 2012 | $9.22 B(+75.8%) | $9.22 B(-30.2%) |
| Dec 2011 | - | $13.22 B(-0.3%) |
| Sep 2011 | - | $13.25 B(+174.7%) |
| Jun 2011 | - | $4.83 B(-8.1%) |
| Mar 2011 | $5.25 B(+14.6%) | $5.25 B(+14.0%) |
| Dec 2010 | - | $4.60 B(+2.7%) |
| Sep 2010 | - | $4.48 B(+7.7%) |
| Jun 2010 | - | $4.16 B(-9.2%) |
| Mar 2010 | $4.58 B(-3.9%) | $4.58 B(-0.1%) |
| Dec 2009 | - | $4.58 B(-4.1%) |
| Sep 2009 | - | $4.78 B(+0.3%) |
| Mar 2009 | $4.77 B(+11.1%) | $4.77 B(+5.6%) |
| Dec 2008 | - | $4.52 B |
| Mar 2008 | $4.29 B(+14.4%) | - |
| Mar 2007 | $3.75 B(-9.5%) | - |
| Mar 2006 | $4.15 B(+21.6%) | - |
| Mar 2005 | $3.41 B(-4.1%) | - |
| Mar 2004 | $3.56 B(+21.7%) | - |
| Mar 2003 | $2.92 B(+4.4%) | - |
| Mar 2002 | $2.80 B(+2.1%) | - |
| Mar 2001 | $2.74 B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total current liabilities?
- What is the all time high annual current liabilities for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual current liabilities year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly current liabilities year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total current liabilities?
The current annual current liabilities of TAK is $15.28 B
What is the all time high annual current liabilities for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total current liabilities is $23.03 B
What is Takeda Pharmaceutical Company Limited annual current liabilities year-on-year change?
Over the past year, TAK annual total current liabilities has changed by -$3.34 B (-17.95%)
What is Takeda Pharmaceutical Company Limited quarterly total current liabilities?
The current quarterly current liabilities of TAK is $13.36 B
What is the all time high quarterly current liabilities for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total current liabilities is $23.03 B
What is Takeda Pharmaceutical Company Limited quarterly current liabilities year-on-year change?
Over the past year, TAK quarterly total current liabilities has changed by -$3.36 B (-20.07%)